Skip to main content

Horizons Marijuana Life Sciences ETF(HMMJ-T)
TSX

Today's Change
Real-Time Last Update

Closing Bell: Horizons Marijuana Life Sciences ETF down on Thursday (HMMJ)

Automated Summaries - The Globe and Mail - Thu Apr 11, 4:02PM CDT

In market activity today, Horizons Marijuana Life Sciences ETF shares closed at $10.59 after opening the day at $10.70. Intraday prices ranged from $10.50 to $10.75.

Share prices dipped -1.12% from the previous day's close of $10.71.

Today across North America, the TSX Composite closed -0.73% at 22199.13, the S&P 500 closed -0.95% at 5160.64, the Dow Jones Industrial Average closed -1.09% at 38461.51 and the Nasdaq Composite closed -0.84% at 16170.36.

Horizons Marijuana Life Sciences ETF has listed on the Toronto Stock Exchange (TSX) under the ticker HMMJ.

A total of 7,704 shares was traded during the last trading day, with total trades of 51, with an average volume of 12,194 over the last 5 days.

The TSX market on the whole today saw 2,898 price advancers against 2,320 declines and 129 unchanged.

During the prior 52 weeks, HMMJ.TO has traded as high as $11.91 (April 04,2024) and low as $8.07 (October 27,2023). Moreover, in the last 52 weeks, Horizons Marijuana Life Sciences ETF's shares have boosted 2.12%, while they have boosted 13.99% year-to-date.

Following today's trading, Horizons Marijuana Life Sciences ETF has a market capitalization of $88.26 million on a float of 8,241 shares outstanding. Its annual EPS is $None.

Horizons Marijuana Life Sciences ETF is a None company headquartered in, None.

The Horizons Marijuana Life Sciences Index ETF seeks to replicate, to the extent possible, the performance of the North American Marijuana Index, net of expenses. The Index is designed to provide exposure to the performance of a basket of North American publicly listed life sciences companies with significant business activities in the marijuana industry..

Horizons Marijuana Life Sciences ETF's average recommendation is "Strong Sell" based on 0.00 analysts according to Zacks. From those 0 analysts,.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..

More from The Globe